Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Sargentini-Maier ML"'
Autor:
Toublanc N, Sargentini-Maier ML, Lacroix B, Jacqmin P, Stockis A, Toublanc, Nathalie, Sargentini-Maier, Maria Laura, Lacroix, Brigitte, Jacqmin, Philippe, Stockis, Armel
Publikováno v:
Clinical Pharmacokinetics; 2008, Vol. 47 Issue 5, p333-341, 9p
Autor:
Stockis A; UCB Pharma, Braine-l'Alleud, Belgium., Nicolas JM; UCB Pharma, Braine-l'Alleud, Belgium., Sargentini-Maier ML; UCB Pharma, Braine-l'Alleud, Belgium.; Current affiliation: Sanofi, Diegem, Belgium., Krauwinkel W; UCB Pharma, Braine-l'Alleud, Belgium.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2023 Nov; Vol. 12 (11), pp. 1121-1127. Date of Electronic Publication: 2023 May 22.
Autor:
de Witte WEA; Sanofi R&D, Ghent, Belgium. wilbert.dewitte@esqlabs.com.; esqLABS GmbH, Saterland, Germany. wilbert.dewitte@esqlabs.com., Avery LB; Sanofi R&D, Cambridge, USA., Mackness BC; Sanofi R&D, Cambridge, USA., Van Bogaert T; Sanofi R&D, Ghent, Belgium., Park A; Sanofi R&D, Cambridge, USA., Sargentini-Maier ML; Sanofi R&D, Ghent, Belgium.
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2023 Jun; Vol. 50 (3), pp. 229-241. Date of Electronic Publication: 2023 Mar 06.
Autor:
Bergstrand M; Pharmetheus AB, Uppsala, Sweden., Hansson E; Pharmetheus AB, Uppsala, Sweden., Delaey B; Sanofi, Diegem, Belgium., Callewaert F; Sanofi, Diegem, Belgium., De Passos Sousa R; Sanofi, Lisbon, Portugal., Sargentini-Maier ML; Sanofi, Diegem, Belgium.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2022 Mar; Vol. 62 (3), pp. 409-421. Date of Electronic Publication: 2021 Nov 29.
Autor:
Sargentini-Maier ML; a Clinical Development , Ablynx, a Sanofi company , Zwijnaarde , Belgium., De Decker P; b Pharmacology , Ablynx, a Sanofi company , Zwijnaarde , Belgium., Tersteeg C; c Formerly Pharmacology , Ablynx NV , Zwijnaarde , Belgium., Canvin J; d Medical Safety Evaluation , Sanofi , Guilford , UK., Callewaert F; e Medical Affairs , Sanofi , Diegem , Belgium., De Winter H; f Formerly Clinical Development , Ablynx NV , Ghent , Belgium.
Publikováno v:
Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2019 Jun; Vol. 12 (6), pp. 537-545. Date of Electronic Publication: 2019 Apr 28.
Autor:
Stockis A; UCB Pharma, Braine l'Alleud, Belgium. Electronic address: Armel.Stockis@ucb.com., Sargentini-Maier ML; UCB Pharma, Braine l'Alleud, Belgium., Brodie MJ; Epilepsy Unit West Glasgow, ACH-Yorkhill, Glasgow, Scotland, UK.
Publikováno v:
Epilepsy research [Epilepsy Res] 2016 Dec; Vol. 128, pp. 163-168. Date of Electronic Publication: 2016 Nov 09.
Autor:
Stockis A; UCB Pharma, Clinical Pharmacology, Braine-l'Alleud, Belgium. armel.stockis@ucb.com, Sargentini-Maier ML, Horsmans Y
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2013 Jun; Vol. 53 (6), pp. 633-41. Date of Electronic Publication: 2013 May 03.
Autor:
Sargentini-Maier ML; UCB Pharma, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium., Sokalski A, Boulanger P, Jacobs T, Stockis A
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2012 Dec; Vol. 52 (12), pp. 1927-33. Date of Electronic Publication: 2012 Jan 10.
Autor:
Plan EL; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. elodie.plan@farmbio.uu.se, Elshoff JP, Stockis A, Sargentini-Maier ML, Karlsson MO
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2012 May; Vol. 91 (5), pp. 820-8. Date of Electronic Publication: 2012 Mar 21.